Embera's phase I study of EMB-001 to receive funding from Sounds Affects Life July 4, 2014 No Comments
Orexo reports phase III data on Zubsolv for induction of buprenorphine maintenance therapy June 25, 2014 No Comments
Double-blind trial finds (S)-(-)-OSU-6162 effective in treating alcohol dependence May 9, 2014 No Comments
Southwest Research Institute receives contract extension for cyanide antidote March 31, 2014 No Comments
RSS